AI
PASG icon

Acuitas Investments’s Passage Bio PASG Stock Holding History

Acuitas Investments’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,591
Closed -$375K – 127
2024
Q2 		$375K Buy
23,591
+126
+0.5% +$3.08K 0.2% 106
2024
Q1 		$634K Buy
23,465
+2,578
+12% +$62K 0.32% 91
2023
Q4 		$422K Sell
20,887
-21
-0.1% -$290 0.22% 103
2023
Q3 		$275K Sell
20,908
-1
-0% -$16 0.16% 103
2023
Q2 		$394K Buy
+20,909
New +$414K 0.23% 95

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acuitas Investments's PASG Position: Q3 2024 in Review

Acuitas Investments sold out of Passage Bio (PASG) in Q3 2024, closing a stake of 23,591 shares — an estimated $375K sold.

Acuitas Investments first reported a position in PASG in Q2 2023 and held it in 5 quarters. The position peaked at $634K in Q1 2024. 44 funds tracked by Wall St. Rank hold PASG as of Q3 2024.

  • Acuitas Investments reported no remaining Passage Bio position as of Q3 2024 after selling out during the quarter.
  • Acuitas Investments sold 23,591 Passage Bio shares in Q3 2024, an estimated $375K.
  • Acuitas Investments first reported a position in Passage Bio in Q2 2023 and held it in 5 quarters.
  • Acuitas Investments's Passage Bio position peaked at $634K in Q1 2024.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q3 2024.

Based on Acuitas Investments's 13F filing for Q3 2024, filed 7 Nov 2024.